<a href="https://community.sciex.com/author/commmunitysuperuser/" target="_self">SCIEX Community</a>

SCIEX Community

Simplifying Polar Pesticides Within a Single Analysis

Feb 15, 2018 | Blogs, Food / Beverage | 0 comments

Glyphosate is a polar pesticide widely used as a garden herbicide. It is an ingredient in the world’s bestselling weed killer, which farmers consider one of their best solutions to their super weed problems.

However, the chemical has become one of the most controversial topics as concerns about health implications increase. What’s more, lack of rigorous testing methods has also drawn criticism. Yet, regulators across seem to have differing opinions on these issues and its widely used in farming is still authorized.

Many contemporary methods fail to address reproducibility and sensitivity. Consequently, labs are seeking even more efficient and robust analytical testing methods to help identify as many polar pesticides in food, feed, and environment, within in a single analysis.  

There are 2 constraints you need to know need when evaluating glyphosate testing methods:

  1. While ion chromatography has been shown to be beneficial for separation, there are downsides. The need for a suppressor is detrimental to MS analysis and the inefficiency of having to change inlet systems on a mass spectrometers systems that heavily work in reverse-phase LC.
  2. Previous analytical strategies, especially for LC-MS/MS analysis, have required laborious and often time-consuming derivatization of glyphosate and its metabolites to allow the polar nature of the compounds to be identified more easily under reverse-phase LC-MS conditions.

The good news? SCIEX has teamed up with NofaLab, a Rotterdam-based contract testing laboratory to develop a non-derivatized method.

This new method, is based on ion chromatography and optimized on the SCIEX 6500+ QTRAP® LC-MS/MS System, has high sensitivity, linearity, and reproducibility for food, feed, and water samples.

Download a content pack to learn more about this robust and sensitive method and how you can stay ahead of your glyphosate analysis. The content pack includes:

  • Comprehensive tech note which details the performance of this method
  • Recorded webinar from Wim Broer at Nofalab Laboratories
  • Overview flyer

 

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

Community Manager
Tags
biotherapeutic developmentblazechargecompanycoupledevelopmentFood / Beveragejobmachinemassmoneynewnumberpowerproteinrapidsystemtechnologytimevariantwork

0 Comments

Submit a Comment

SCIEX Now™ support network
The destination for all your support needs.
Contact support

The power of precision

Visit Danaher site Danaher
© Copyright 2024 SCIEX

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures. Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks). Echo® and Echo® MS + system are trademarks or registered trademarks of Labcyte, Inc. in the United States and other countries, and are being used under license.

Pin It on Pinterest

Share This

Share this post with your network